Upcoming Webinars Archived Webinars Training Vitals Host A Webinar About Get Updates Contact

In an Imperfect World: Strategies for Psychiatric Clinical Trials


Studies involving psychiatry drugs may be uniquely challenging.

Tweetables from this article:

Tweet: Not all symptomatic improvement in mental disorders can necessarily be tied to the product under study. http://ctt.ec/lf2Zz+ Not all symptomatic improvement in mental disorders can necessarily be tied to the product under study.

Share this!

September 16, 2016 | by Megan Sims

In a perfect world, clinical drug trials draw conclusive results from objective observations. But we don’t live in that world, and we doubt you do, either.

Studies involving psychiatry drugs may be uniquely challenging. Ensuring that trial data accurately captures a compound’s safety and efficacy potential requires that you account for challenges inherent in working with a mentally ill population. Observing changes in the disease under study is partly a subjective process, and that creates risk of undue influence that the patient and/or investigator may not recognize.

To further complicate things, not all symptomatic improvement in mental disorders can necessarily be tied to the product under study. Some changes may result from unrelated factors whose therapeutic effect erodes the efficacy signal of a potential treatment.

On Tuesday, September 20, join two experts from Premier Research for a revealing look at these challenges. Krista Armstrong, Vice President of Strategic Development, and Susan Kozauer, Senior Medical Director, will present Conclusive Results: Strategies for Collecting Quality Data in Psychiatric Clinical Trials. The hour-long session, beginning at 11 a.m. Eastern time, will explore a range of factors that — if identified and mitigated early in the development process — can maximize the potential for conclusive study results. Look for a particular focus on:

  • Study design considerations
  • Site factors
  • Subject selection and eligibility
  • Data surveillance

The neuroscience experts at Premier Research have performed more than 150 neuroscience studies in just the past five years, their work touching more than 27,000 patients afflicted with all major central nervous system disorders. Register today for what is sure to be an informative presentation.

Keywords: Premier Research, Psychiatry, Clinical Trials



        Share this with your colleagues!

        Adding Value to your Food Products by Adding Live Cultures: Interview with a Probiotic Expert

        February 17, 2017 - To better understand how probiotics can be added to food products, and the benefits of probiotic fortification for both food manufacturers and consumers, I spoke with Michael Bush, president of the probiotic research and product development company, Ganeden. With over 20 years of experience in business and a degree in biomedical technology, Bush knows how formulating with functional ingredients like probiotics can help food and beverage companies add value to their products and increase sales.

        Dirty Little Secret: How Clean Are Restaurant Tablets?

        February 8, 2017 - The digital revolution may well make it easier or more fun to process your order, but these devices shouldn’t be an overlooked source of potential cross-contamination.

        5 Ways Mature Material Handling Workflows Can Benefit Your Manufacturing Business

        February 2, 2017 - Sometimes inefficiencies in material handling workflows are obvious, however without the right tools to improve these processes, manufacturers could get stuck with a sub-par process. So what defines a mature material handling workflow?


        Top Ten Webinar Production Tips of 2016


        ICH-GCP E6(R2) – Live Q&A with GCP Inspector and Investigator Site Perspectives

        Addressing HACCP of Frictionless Devices in the Food Service Industry

        Mid-Study Changes: Keeping Your Clinical Trial on Track with EDC

        The Growing Formulation Trend: Probiotics

        Copyright © 2016-2017 Honeycomb Worldwide Inc.